Enzolytics, Inc. (OTCMKTS:ENZC) Sees Large Drop in Short Interest

Enzolytics, Inc. (OTCMKTS:ENZC) was the target of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 1,800 shares, a decrease of 99.6% from the February 28th total of 499,900 shares. Based on an average daily volume of 7,236,000 shares, the days-to-cover ratio is presently 0.0 days.

Enzolytics Trading Down 14.3 %

ENZC stock opened at $0.00 on Friday. Enzolytics has a one year low of $0.00 and a one year high of $0.01.

About Enzolytics

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.